Cosmos Health Launches Fort18 After 5.1× Clinical Endurance Boost
Cosmos Health has introduced Fort18, a men's sexual stamina supplement in the United States formulated with a proprietary five-ingredient botanical blend evaluated in published clinical research. Published data reported a 5.1-fold endurance improvement over placebo in eight weeks, while the U.S. sexual health supplement market, valued at $965.8 million in 2023, is projected to reach $1.93 billion by 2030.
1. Product Launch
Cosmos Health has rolled out Fort18 in the United States, marking its expansion of the science-based 18 Series into the men’s sexual stamina category. The supplement delivers 500mg twice daily of a proprietary blend designed to support hormonal, neuronal and vascular pathways.
2. Published Clinical Research
A randomized, double-blind, placebo-controlled study in 60 healthy men reported a 5.1-fold improvement in endurance versus placebo over eight weeks, with significant results by Week 4 and no safety issues observed.
3. U.S. Market Opportunity
The U.S. sexual health supplement market was estimated at $965.8 million in 2023 and is forecast to nearly double to $1.93 billion by 2030, representing a CAGR of 10.4% and underscoring substantial growth potential.
4. Expansion of the 18 Series
Fort18 joins existing products Noor18, Liv18 and Cur18, advancing Cosmos Health’s goal of 18 science-backed nutraceuticals. Each product in the series features proprietary ingredients, published clinical studies and dosing aligned with research findings.